<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:media="http://search.yahoo.com/mrss/"
	
	>

<channel>
	<title>Marcus Alexander</title>
	<link>https://marcusalexander.io</link>
	<description>Marcus Alexander</description>
	<pubDate>Tue, 29 Jun 2021 22:39:19 +0000</pubDate>
	<generator>https://marcusalexander.io</generator>
	<language>en</language>
	
		
	<item>
		<title>1</title>
				
		<link>https://marcusalexander.io/1</link>

		<pubDate>Tue, 29 Jun 2021 22:39:17 +0000</pubDate>

		<dc:creator>Marcus Alexander</dc:creator>

		<guid isPermaLink="true">https://marcusalexander.io/1</guid>

		<description>01Microbiome Networks&#38;nbsp;
Organization of the human microbiome across social networks can shed new light on collective immunity and contagion of disease&#38;nbsp; ︎
</description>
		
	</item>
		
		
	<item>
		<title>2</title>
				
		<link>https://marcusalexander.io/2</link>

		<pubDate>Tue, 29 Jun 2021 22:39:17 +0000</pubDate>

		<dc:creator>Marcus Alexander</dc:creator>

		<guid isPermaLink="true">https://marcusalexander.io/2</guid>

		<description>02Brain Tumor Genomics
Using single-cell RNA-Seq we can identify the cancer stem cell population that is responsible for GBM resistance to therapy ︎

</description>
		
	</item>
		
		
	<item>
		<title>3</title>
				
		<link>https://marcusalexander.io/3</link>

		<pubDate>Tue, 29 Jun 2021 22:39:18 +0000</pubDate>

		<dc:creator>Marcus Alexander</dc:creator>

		<guid isPermaLink="true">https://marcusalexander.io/3</guid>

		<description>
03Networks Interventions

Public health field interventions can mobilize social networksto accelerate adoption ︎
</description>
		
	</item>
		
		
	<item>
		<title>Microbiome and Networks</title>
				
		<link>https://marcusalexander.io/Microbiome-and-Networks</link>

		<pubDate>Tue, 29 Jun 2021 22:39:19 +0000</pubDate>

		<dc:creator>Marcus Alexander</dc:creator>

		<guid isPermaLink="true">https://marcusalexander.io/Microbiome-and-Networks</guid>

		<description> 01 Research&#38;nbsp;
Microbiome Networks
&#60;img width="2050" height="1136" width_o="2050" height_o="1136" data-src="https://freight.cargo.site/t/original/i/cc522a470a1a65d50f491306d9906e58b3d4ed8ab7f0f68b3a3a2f7cb44c19f3/two_village_networks.png" data-mid="112826850" border="0"  src="https://freight.cargo.site/w/1000/i/cc522a470a1a65d50f491306d9906e58b3d4ed8ab7f0f68b3a3a2f7cb44c19f3/two_village_networks.png" /&#62;
Distribution of respiratory disease across two village social networks in Honduras
	Human Microbiome and Social Networks in Central America.

	





































The purpose of the project is to describe the relationship
between social networks and the distribution of the gut microbiome in human communities.
We focus on a set of Honduran villages, where our lab has mapped
sustained face-to-face networks of interactions, sequenced gut microbiome
samples, and collected health measures and microbiome survey responses.








Collaborators: Nicholas A. Christakis (PI), Ilana Brito (PI), Francesco Beghini, Shivkumar Vishnempet, Drew Prinster, Eric Liu, Chengqi Xu&#38;nbsp;&#38;nbsp;
Although the
human body contains as many bacteria as human cells, and there are about 200
times more bacterial genes than there are human genes, only a small number of
bacterial species that colonize humans are known (perhaps &#38;lt; 5 percent)&#38;nbsp;[1].&#38;nbsp;Little is known about the human microbiome because conditions necessary to grow
the bacteria in the lab are difficult to reproduce. Recent advances in
sequencing and the development of metagenomics make it possible to analyze the
entire human microbiome at once. This involves sampling the microbiome and analyzing
all of its DNA at once, taking advantage of supercomputing resources and
advanced alignment algorithms to assemble genomes of previously unknown species
and identify functional bacterial genes playing a role in normal human
physiology and disease [2].



Previous studies
suggest that the bacteria that &#38;nbsp;live in
our gut play an important role in the normal functioning of the human body,
including maturation of the immune system; regulation of endocrine function and
neurologic signaling; maintenance of bone density; modification of drugs; and
elimination of exogenous toxins [3].&#38;nbsp; And, conversely, studies have identified a
potential role of the microbiome not only in various bowel diseases, but also
in atherosclerosis [4], obesity [5], diabetes [6-7],&#38;nbsp;asthma [8-9],&#38;nbsp;autoimmune disorders, and even in brain function and mental health conditions
such as depression. 



An important
aspect of the human microbiome is that the bacteria that compose it have
co-evolved together with human populations. Previous studies of the biological
and sociological features of human social interactions suggest that natural
selection has shaped social network structure and function [10-14]. While early research suggests that social relationships, especially within the
household, are involved in gut microbiome transmission, the distribution of the
human gut microbiome across social networks has not been studied [15-17]. Unlike our understanding of pathogens and the dynamics of infectious diseases,
it is not known what role social transmission plays in the composition of the
healthy microbiome. Furthermore, the link between the gut microbiome and
non-infectious diseases described above implies that the spread of the gut
microbiome across social networks may help explain epidemiology of obesity,
cardiovascular disease, and other.



The proposed
research is the first attempt to study the human gut microbiome metagenome
across population-level networks of social interaction, examining the impact of
the microbiome on community health. By focusing on a population in Central
America, the study will also contribute to our understanding of the gut
microbiome diversity in low and middle-income countries, as well as in
Indigenous populations. The study aims to identify social
highly-transmissible strains or mobile genes associated with either increased
or decreased risk of disease, leading to better epidemiological models and
novel therapeutic strategies. 



 Our hypothesis is that different gut bacterial species will
cluster in distinct regions of social networks, and that these clusters will be
associated with increased risk of elevated BMI, HbA1 and MAP, even after
adjusting for known risk factors. Specifically, this would imply a
statistically-significant correlation between topology measures of the village
social networks and the same topology measures of co-occurrence networks of gut
bacterial species and clades in the village.


	Watch an interview about our work on microbiome and social networks.
	








Lloyd-Price J, Mahurkar A, Rahnavard G, et al., “Strains, functions and dynamics in the expanded Human Microbiome Project,” Nature 2017; 550(7674): 61-66.Lloyd-Price J, Abu-Ali G, Huttenhower C, “The healthy human microbiome. Genome&#38;nbsp;Medicine 2016; 8(1): 51.Lynch SV and Pedersen O, “The human intestinal microbiome in health and disease,” New England Journal of Medicine 2016; 375: 2369-2379.Wilson Tang WH, Wang Z, Levison BS, et al., “Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk,” New England Journal of Medicine 2013; 368: 1575-1584.Turnbaugh PJ, Hamady M, Yatsunenko T, et al., “A core gut microbiome in obese and lean twins,” Nature 2009; 457: 480-484.Qin J, Li Y, Cai Z, et al., “A metagenome-wide association study of gut microbiota in type 2 diabetes,” Nature 2012; 490: 55-60.Karlsson FH, Tremaroli V, Nookaew I, et al., “Gut metagenome in European women with normal, impaired and diabetic glucose control,” Nature 2013; 498: 99-103.Fujimura KE, Sitarik AR, Havstad S, et al., “Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation,” Nature Medicine 2016; 22: 1187-1191.Arrieta MC, Stiemsma LT, Dimitriu PA, et al., “Early infancy microbial and metabolic alterations affect risk of childhood asthma,” Science Translational Medicine 2015; 7: 307ra152-307ra152.Fowler JH, Dawes CT, and Christakis NA, “Model of genetic variation in human social networks,” Proceedings of the National Academy of Sciences 2009; 106: 1720-1724.Fowler JH, Settle JE, and Christakis NA, "Correlated Genotypes in Friendship Networks," Proceedings of the National Academy of Sciences 2011; 108(5): 1993-1997.Christakis NA and Fowler JH, “Friendship and Natural Selection,” Proceedings of the National Academy of Sciences 2014; 111: 10796-10801.Nishi A, Alexander MA, Fowler JH, and Christakis NA, “Assortative Mating at Loci Under Recent Natural Selection in Humans,” Bio Systems 2020; 187: 104040.Kim DA, Benjamin EJ, Fowler JH, and Christakis NA, “Social Connectedness Is Associated with Fibrinogen Level in a Human Social Network,” Proceedings of the Royal Society B 2016; 283: 20160958.Brito IL, Yilmaz S, Huang K, Xu L, Jupiter SD, Jenkins AP, Naisilisili W, Tamminen M, Smillie CS, Wortman JR, Birren BW, Xavier RJ, Blainey PC, Singh AK, Gevers D, and Alm EJ, “Mobile genes in the human microbiome are structured from global to individual scales,” Nature 2016; 535(7612): 435-439.Sarkar A, Harty S, Johnson KV-A, et al, “Micorbial transmission in animal social networks and the social microbiome,” Nature Ecology &#38;amp; Evolution 2020; 4:1020-1035.Brito IL, Gurry T, Zhao S, et al. “Transmission of human-associated microbiota along family and social networks,” Nature Microbiology 2019; 4:964-971.Shakya HB, Stafford D, Hughes DA, Keegan T, Negron R, Broome J, McKnight M, Nicoll J, Nelson JA, Iriarte E, Fowler JH, Christakis NA, “Exploiting social influence to magnify population-level behavior change in maternal and child health: A Randomized controlled trial of network targeting algorithms in rural Honduras,” BMJ Open 2016; 7:e012996.
&#38;nbsp;</description>
		
	</item>
		
		
	<item>
		<title>Brain Tumor Genomics</title>
				
		<link>https://marcusalexander.io/Brain-Tumor-Genomics</link>

		<pubDate>Tue, 29 Jun 2021 22:39:19 +0000</pubDate>

		<dc:creator>Marcus Alexander</dc:creator>

		<guid isPermaLink="true">https://marcusalexander.io/Brain-Tumor-Genomics</guid>

		<description> 02&#38;nbsp;Research
Brain Tumor Genomcis
Single-cell viral oncogenesis Ashish H. Shah (PI)


	A study of single-cell RNA-Seq to understand activation of antiviral immune response in glioblastoma and its role in potentiating immune checkpoint inhibition.

Single-cell transcriptiome of glioma stem cells Luis F. Parada (PI)


	A study of single-cell RNA-Seq in order to identify gene signature of glioblastoma cancer stem cell, and identify potential new targets for therapy.
&#60;img width="2458" height="1100" width_o="2458" height_o="1100" data-src="https://freight.cargo.site/t/original/i/d184cc28430dae14399b62a16444cabb53b2643618fe768de85607ae8fc40a23/Neftel_picture.png" data-mid="112931860" border="0"  src="https://freight.cargo.site/w/1000/i/d184cc28430dae14399b62a16444cabb53b2643618fe768de85607ae8fc40a23/Neftel_picture.png" /&#62;
Single-cell RNA-Seq identifies 7 distinct cell types across 20 adult GBM tumors (Data from Neftel, 2019)&#38;nbsp;


	Single-cell transcriptiome of glioma stem cells Luis F. Parada (PI)


	A study of single-cell RNA-Seq in order to identify gene signature of glioblastoma cancer stem cell, and identify potential new targets for therapy.

Single-cell multiomic profile of pituitary adenomas Prashant Chittiboina (PI)


	A study of epigenomics of pituitary adenomas and normal pituitary cells to identify transcriptional regulation mechanisms responsible for pathogenesis of spontaneous pituitary adenomas.
&#60;img width="1902" height="1256" width_o="1902" height_o="1256" data-src="https://freight.cargo.site/t/original/i/e59e0ffa3c1530d9c89b7833d959bee2e7a5f47fa59a645e4d3da6164f8e7e95/LGG_metabolism.png" data-mid="112931763" border="0"  src="https://freight.cargo.site/w/1000/i/e59e0ffa3c1530d9c89b7833d959bee2e7a5f47fa59a645e4d3da6164f8e7e95/LGG_metabolism.png" /&#62;
Differentially activated metabolic pathways across different tumors (Data form TCGA)
Metabolic pathways of low grade gliomas Jack Goodman (collaborator)


	We use metabolic pathway reactivity scores from transcriptiome sequencing data to identify low grade glioma tumors associated with prolonged patient survival.Metablic pathway classification of tumors and prognosis of survival
 Jack Goodman (collaborator)

	We use survival modeling based on differential metabolic pathway activation to offer novel classificaiton system for tumors across all tissue types and use metabolic classification of tumors to identify patients with prolonged survival.
</description>
		
	</item>
		
	</channel>
</rss>